Bausch Health agrees to pay $45 million to settle U.S. charges of misleading disclosures

WASHINGTON (Reuters) – Canada-based Bausch Health Companies Inc has agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in Securities and Exchange Commission filings and earnings presentations, the SEC said on Friday.

Read More